Thomas R. Staab II

Insider Reports History

Entity
Individual
Location
C/O Inspire Pharmaceuticals, Inc., 4222 Emperor Blvd., Suite 200, Durham, NC
Signature
/s/ Thomas R. Staab, II
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas R. Staab II:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LENSAR, Inc. Chief Financial Officer Common Stock 162K $430K $2.65 Aug 8, 2024 Direct
LENSAR, Inc. Chief Financial Officer Stock Option (Right to Buy) 19.8K Aug 8, 2024 Direct

Insider Reports Filed by Thomas R. Staab II

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LNSR LENSAR, Inc. Aug 8, 2024 2 $9.28K 4 Aug 12, 2024 Chief Financial Officer
LNSR LENSAR, Inc. Jan 11, 2024 2 -$8.21K 4 May 8, 2024 Chief Financial Officer
LNSR LENSAR, Inc. Jan 11, 2023 2 $0 4 Jan 13, 2023 Chief Financial Officer
LNSR LENSAR, Inc. Dec 6, 2022 2 $8.7K 4 Dec 7, 2022 Chief Financial Officer
LNSR LENSAR, Inc. Jan 11, 2022 2 $0 4 Jan 13, 2022 Chief Financial Officer